Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy
Clinical trial NCT01887314 · COMPLETED
Trial details
- NCT number
- NCT01887314
- Sponsor
- Helsinn Healthcare SA
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-09-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.